Man Sun, Dan Zang, Chen-Guang Liu, Huan Zhou, Jun Chen
{"title":"Construction of a prognostic model for lung adenocarcinoma based on disulfidptosis-related lncRNAs.","authors":"Man Sun, Dan Zang, Chen-Guang Liu, Huan Zhou, Jun Chen","doi":"10.21037/tcr-2024-2256","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer, and it has a high incidence and poor prognosis. Disulfidptosis is a novel form of death induced by disulfide stress caused by excessive intracellular cystine accumulation under glucose starvation conditions. This study investigated the significance of disulfidptosis-related long non-coding RNAs (DRlncRNAs) in the risk assessment and prognosis prediction of LUAD.</p><p><strong>Methods: </strong>RNA sequencing data and clinical information of LUAD patients were obtained from The Cancer Genome Atlas database. Differentially expressed genes associated with disulfidptosis were screened using univariate Cox regression analysis. A prognostic model was constructed using the least absolute shrinkage and selection operator and the Cox regression analysis to classify patients into high- and low-risk groups. Time-dependent receiver operating characteristic, C-index, and Kaplan-Meier curves were plotted and compared to evaluate the predictive ability of the prognostic model. Functional gene set enrichment analysis (GSEA) and single-sample GSEA were used to explore the characteristics of enrichment pathways, immune-related functions, and treatment response in the high- and low-risk groups.</p><p><strong>Results: </strong>A risk prognostic model was constructed consisting of eight DRlncRNAs (<i>ATXN1-AS1, AC018645.3, AC096733.2, AL049836.1, LINC01711, AF131215.5, AC027288.1,</i> and <i>AL606489.1</i>). Univariate and multifactorial Cox analyses showed that the model was a prognostic factor independent of multiple clinicopathologic parameters.</p><p><strong>Conclusions: </strong>The developed 8-lncRNA prognostic model serves as a valid biomarker for predicting LUAD prognosis and provides potential therapeutic insights. Targeting DRlncRNAs may contribute to improved prognosis and guide future therapeutic strategies.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 6","pages":"3420-3437"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12268875/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-2024-2256","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer, and it has a high incidence and poor prognosis. Disulfidptosis is a novel form of death induced by disulfide stress caused by excessive intracellular cystine accumulation under glucose starvation conditions. This study investigated the significance of disulfidptosis-related long non-coding RNAs (DRlncRNAs) in the risk assessment and prognosis prediction of LUAD.
Methods: RNA sequencing data and clinical information of LUAD patients were obtained from The Cancer Genome Atlas database. Differentially expressed genes associated with disulfidptosis were screened using univariate Cox regression analysis. A prognostic model was constructed using the least absolute shrinkage and selection operator and the Cox regression analysis to classify patients into high- and low-risk groups. Time-dependent receiver operating characteristic, C-index, and Kaplan-Meier curves were plotted and compared to evaluate the predictive ability of the prognostic model. Functional gene set enrichment analysis (GSEA) and single-sample GSEA were used to explore the characteristics of enrichment pathways, immune-related functions, and treatment response in the high- and low-risk groups.
Results: A risk prognostic model was constructed consisting of eight DRlncRNAs (ATXN1-AS1, AC018645.3, AC096733.2, AL049836.1, LINC01711, AF131215.5, AC027288.1, and AL606489.1). Univariate and multifactorial Cox analyses showed that the model was a prognostic factor independent of multiple clinicopathologic parameters.
Conclusions: The developed 8-lncRNA prognostic model serves as a valid biomarker for predicting LUAD prognosis and provides potential therapeutic insights. Targeting DRlncRNAs may contribute to improved prognosis and guide future therapeutic strategies.
期刊介绍：
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
